CymitQuimica logo

3-Deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib

CAS:

Ref. 3D-FD92873

5mg
Discontinued
10mg
Discontinued
25mg
Discontinued
50mg
Discontinued
100mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

3-Deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib
Biosynth

Product Information

Name:3-Deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib
Brand:Biosynth
Description:Gefitinib is a substance that is used in research. It is an inhibitor of the protein tyrosine kinase receptor type A (epidermal growth factor receptor, or EGFR). This chemical inhibits the binding of epidermal growth factor to its receptor and prevents activation of the downstream signaling pathways. Gefitinib has been shown to be effective against non-small cell lung cancer cells, which overexpress EGFR. The compound undergoes recrystallization as well as a process where triethyl orthoformate reacts with cyanophenyl chloride to give 3-deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib. Impurities are removed by the use of a column chromatography purification process. Gefitinib was approved for use in Japan in 2004 and in Europe and America in 2006. It is currently being investigated for its potential side effects on patients with asthma and diabetes
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:446.9 g/mol
Formula:C22H24ClFN4O3
Purity:Min. 95%
InChI:InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-17(23)18(24)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
InChI key:InChIKey=WTDLLXPLBLPTEP-UHFFFAOYSA-N
SMILES:COc1cc2ncnc(Nc3ccc(Cl)c(F)c3)c2cc1OCCCN1CCOCC1

Inquiry about discontinued product: 3-Deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.